"Price decreases are a good thing for Canadian citizens as it reduces their financial burden, but unfortunately, it has knock-on effects for pharmaceutical companies, especially those…
In Conversation
"The innovative power and capacity in Canada, its tremendous manufacturing potential and the highly skilled workforce needs to be put into a position to successfully grow…
"We are indeed expecting tremendous growth in the animal health market; industry experts expect a growth rate of five to eight percent per year."
"Health Canada has done a good job of harmonizing the approval process based upon safety and efficacy, but there are numerous agencies, both federal and provincial,…
"While we may not be the first in terms of sales in Canada, we are certainly the largest innovative Canadian healthcare company."
"Pharmascience already offers a great platform to distribute and market biosimilars in the markets and therapeutic areas we are strong in."
"One of our key priorities will be around new initiatives that will ensure we continue to be a strong player in the renal space in Canada."
"Pediapharm is unique, in that we master the pediatric market in Canada and are able to bring all key stakeholders in the field together and draw…
"We will focus more of our efforts on the market in Canada, 2018 promises to be the turning year for this."
"Canada is one of those markets where if you file a product dossier completely as per current regulations, you can count on timely approvals and reasonable…
Our model is based on leveraging the federal investment with co-funding from multiple sources
"Medelys is always up-to-date, and in the treatment of joint pain and skin regeneration, there is still room for improvement in the formulation of our products."
